Our #safety committee, the #PRAC, recommended new measures to minimise the risk of #meningioma with 💊 containing #nomegestrol or #chlormadinone.
It also started a review of risks of neurodevelopmental disorders with #topiramate.
👉https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-4-7-july-2022

🐦🔗: https://nitter.eu/EMA_News/status/1545355046187110406